Predictive value of phase I trials for safety and final approved dose in later trials: Analysis of 33,845 patients. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback